October 15, 2021

Azurity Pharmaceuticals, Inc. v. Bionpharma Inc.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. January 11, 2023

    Azurity Can't Duck Bionpharma's Sham Suit Claims

    A federal judge has refused to throw out Bionpharma's allegations that Azurity Pharmaceuticals Inc. filed a series of anti-competitive lawsuits over a blood pressure drug, saying it was too early to rule on various factual issues.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS